461 related articles for article (PubMed ID: 25085684)
1. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
[TBL] [Abstract][Full Text] [Related]
2. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
4. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
5. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
7. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
10. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.
Facciorusso A; Del Prete V; Antonino M; Neve V; Crucinio N; Di Leo A; Carr BI; Barone M
J Gastroenterol Hepatol; 2014 Nov; 29(11):1905-10. PubMed ID: 24731153
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
12. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
15. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.
Toshikuni N; Takuma Y; Goto T; Yamamoto H
Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175
[TBL] [Abstract][Full Text] [Related]
17. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients.
Montasser MF; Shaker MK; Albreedy AM; Montasser IF; El Dorry A
J Dig Dis; 2014 Dec; 15(12):676-83. PubMed ID: 25214183
[TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
Peng ZW; Liang HH; Chen MS; Zhang YJ; Li JQ; Zhang YQ; Lau WY
Eur J Surg Oncol; 2008 Feb; 34(2):166-72. PubMed ID: 17851020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
